Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or
Amicus Therapeutics (FOLD)
Amicus Therapeutics (FOLD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,255,031
  • Shares Outstanding, K 293,246
  • Annual Sales, $ 329,230 K
  • Annual Income, $ -236,570 K
  • 60-Month Beta 0.83
  • Price/Sales 9.99
  • Price/Cash Flow N/A
  • Price/Book 24.69
Trade FOLD with:

Options Overview Details

View History
  • Implied Volatility 56.77% ( +3.46%)
  • Historical Volatility 51.75%
  • IV Percentile 47%
  • IV Rank 48.50%
  • IV High 91.49% on 08/08/23
  • IV Low 24.09% on 06/15/23
  • Put/Call Vol Ratio 999.99
  • Today's Volume 26
  • Volume Avg (30-Day) 301
  • Put/Call OI Ratio 0.20
  • Today's Open Interest 42,868
  • Open Int (30-Day) 42,763

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/23
See More
  • Average Estimate 0.00
  • Number of Estimates 7
  • High Estimate 0.35
  • Low Estimate -0.10
  • Prior Year -0.19
  • Growth Rate Est. (year over year) N/A

Price Performance

See More
Period Period Low Period High Performance
1-Month
9.70 +13.14%
on 11/10/23
11.85 -7.38%
on 11/08/23
-0.60 (-5.22%)
since 11/03/23
3-Month
9.70 +13.14%
on 11/10/23
13.52 -18.82%
on 09/12/23
-1.67 (-13.24%)
since 09/05/23
52-Week
9.70 +13.14%
on 11/10/23
14.10 -22.16%
on 08/09/23
-1.39 (-11.28%)
since 12/05/22

Most Recent Stories

More News
Amicus Therapeutics: Q3 Earnings Snapshot

Amicus Therapeutics: Q3 Earnings Snapshot

FOLD : 11.07 (-0.27%)
WuXi Biologics Congratulates Amicus Therapeutics on U.S. FDA Approval for New Treatment for Pompe Disease

/PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global Contract Research, Development and Manufacturing Organization (CRDMO), congratulates...

FOLD : 11.07 (-0.27%)
Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall, Friday, 9/29/2023

Stocks that traded heavily or had substantial price changes on Friday: Nike, Amicus Therapeutics rise; Vail Resorts, Hess fall

OPK : 1.6150 (-0.31%)
MTN : 216.16 (-2.29%)
FOLD : 11.07 (-0.27%)
BLK : 754.45 (-0.26%)
NKE : 115.80 (+0.56%)
Moderna (MRNA) and 2 More Biotech Stocks That Are Worth Watching

Growing demand for personalized medicines and rising adoption of machine learning tools are expected to boost the biotech industry. Therefore, it could be wise to watch fundamentally strong biotech stocks...

FOLD : 11.07 (-0.27%)
IMTX : 9.21 (+0.22%)
MRNA : 78.49 (-1.73%)
TRDA : 14.07 (+3.08%)
Which of These 3 Biotech Stocks Are a Buy, Sell, or Hold?

Advanced medical technologies and the pivotal role of technology in drug development are poised to drive significant growth in the biotech industry. Against this backdrop, should you buy, sell or hold...

FOLD : 11.07 (-0.27%)
INCY : 54.71 (-0.45%)
MGNX : 8.46 (+0.12%)
MRK : 106.15 (+1.04%)
MRNA : 78.49 (-1.73%)
Moderna (MRNA) vs. Amicus Therapeutics (FOLD): Which Biotech Stock Should You Add to Your Portfolio?

Healthcare is considered a reliable defensive sector. So, amid the current uncertain economic landscape, let's determine the more favorable investment option between two prominent pharmaceutical companies,...

FOLD : 11.07 (-0.27%)
MRK : 106.15 (+1.04%)
MRNA : 78.49 (-1.73%)
Amicus Therapeutics: Q2 Earnings Snapshot

Amicus Therapeutics: Q2 Earnings Snapshot

FOLD : 11.07 (-0.27%)
3 Top Biotech Stocks to Purchase Right Away

The ever-rising demand for quality healthcare is expected to benefit the biotech industry. Moreover, favorable government initiatives to boost domestic biotech research and production should boost the...

FOLD : 11.07 (-0.27%)
SGIOY : 11.7789 (-0.93%)
TRDA : 14.07 (+3.08%)
XBI : 79.07 (-0.15%)
Invest in These 3 Biotech Stocks Today

With the biotech industry experiencing significant growth due to the increasing demand for healthcare solutions, fundamentally sound stocks such as Amicus Therapeutics (FOLD), POINT Biopharma Global (PNT),...

DTIL : 0.3980 (+3.06%)
FOLD : 11.07 (-0.27%)
PNT : 13.92 (+1.24%)
Top 3 Biotech Stocks with Breakout Potential

The biotech industry is well-positioned to witness significant growth due to technological advancements and government spending. Moreover, given the sector’s defensive nature, biotech stocks Amicus Therapeutics...

CORT : 26.65 (+1.49%)
FOLD : 11.07 (-0.27%)
HRMY : 32.69 (+4.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Amicus Therapeutics, Inc. is a global patient-centric biotechnology company engaged in the discovery, development and commercialization of a diverse set of novel treatments for patients living with rare metabolic diseases.'The company has one marketed medicine in its portfolio named Galafold which is...

See More

Key Turning Points

3rd Resistance Point 11.70
2nd Resistance Point 11.53
1st Resistance Point 11.32
Last Price 11.07
1st Support Level 10.93
2nd Support Level 10.77
3rd Support Level 10.55

See More

52-Week High 14.10
Fibonacci 61.8% 12.42
Fibonacci 50% 11.90
Fibonacci 38.2% 11.38
Last Price 11.07
52-Week Low 9.70

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar